The changing microbial and clinical profile of reactive arthritis suggests that rheumatologists need to reconsider the approach to its identification and treatment.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach
Scientific Reports Open Access 15 September 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Courcoul, A. et al. A bicentre retrospective study of features and outcomes of patients with reactive arthritis. Joint Bone Spine http://dx.doi.org/10.1016/j.jbspin.2017.01.013 (2017).
Mason, E. et al. Reactive arthritis at the Sydney Sexual Health Centre 1992–2012: declining despite increasing chlamydia diagnoses. Int. J. STD AIDS. 27, 882–889 (2016).
Gracey, E. & Inman, R. D. Chlamydia-induced ReA: immune imbalances and persistent pathogens. Nat. Rev. Rheumatol. 8, 55–59 (2011).
Birnbaum, J., Bartlett, J. G. & Gelber, A. C. Clostridium difficile: an under-recognized cause of reactive arthritis? Clin. Rheumatol. 27, 253–255 (2008).
Henrique da Mota, L. M., Carneiro, J. N., Lima, R. A. C., dos Santos Neto, L. L. & Lima, F. A. C. Reactive arthritis in HIV-infected patients: immunopathogenic aspects [Portuguese]. Acta Reumatol. Port. 33, 279–287 (2008).
Braun, J., Kingsley, G., van der Heijde, D. & Sieper, J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3–6, 1999. J. Rheumatol. 27, 2185–2192 (2000).
Hannu, T. Reactive arthritis. Best Pract. Res. Clin. Rheumatol. 25, 347–357 (2011).
Chaurasia, S., Shasany, A. K., Aggarwal, A. & Misra, R. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy. Clin. Exp. Immunol. 185, 210–218 (2016).
Saxena, N., Misra, R. & Aggarwal, A. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology (Oxford) 45, 1129–1132 (2006).
Braun, J. et al. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2016-209730 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Misra, R., Gupta, L. Time to revisit the concept of reactive arthritis. Nat Rev Rheumatol 13, 327–328 (2017). https://doi.org/10.1038/nrrheum.2017.69
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2017.69
This article is cited by
-
Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach
Scientific Reports (2020)
-
HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review
Rheumatology International (2019)
-
Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up
Clinical Rheumatology (2018)
